2 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Gastroschisis: new trials by email Literature Review of Gastroschisis trials Research Report on Gastroschisis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Direct Peritoneal Resuscitation in Gastroschisis SoC Staged Silo Closure, Peritoneal Dialysis Solution/Dextrose 1.5% - Gastroschisis | Phase 1 | Terminated | University of Arkansas | 3 | 2018-02-01 | 2021-12-20 |
| Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure Glucagon-Like Peptide 2, Glucagon like peptide-2 - Intestinal Failure, Short Bowel Syndrome | Phase 1 / Phase 2 | Terminated | Alberta Children's Hospital | 13 | 2012-01-01 | 2014-12-23 |
Enterocolitis, Necrotizing (1) · Infant Nutrition Disorders (1) · Intestinal Atresia (1) · Intestinal Failure (1) · Malnutrition (1) · Short Bowel Syndrome (1)
Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Hernia (2) · Hernia, Abdominal (2) · Musculoskeletal Abnormalities (2) · Musculoskeletal Diseases (2) · Pathological Conditions, Anatomical (2) · Pathological Conditions, Signs and Symptoms (2) · Digestive System Abnormalities (1) · Digestive System Diseases (1) · Enterocolitis (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Malabsorption Syndromes (1)
Dialysis Solutions (1) · Glucagon-Like Peptide 2 (1)
Alberta Children's Hospital (1) · University of Arkansas (1)
Canada (1) · United States (1)
David Sigalet, MD PhD (1) · Patrick C Bonasso, MD (1) · Samuel Smith, MD (1)